We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
CAT No: C5501
CAS No: 188968-51-6
Synonyms/Alias: Cilengitide;188968-51-6;EMD-121974;2-[(2S,5R,8S,11S)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;Cyclo(L-arginylglycyl-L-alpha-aspartyl-D-phenylalanyl-N-methyl-L-valyl);EMD 121974;Cilengitide [USAN:INN];EMD-12192;EMD121974;Cilengitida;4EDF46E4GI;CILENGITIDE [MI];CILENGITIDE [INN];CILENGITIDE [USAN];CILENGITIDE [MART.];cyclic-Arg-Gly-Asp-D-Phe(N-methyl)Val;CILENGITIDE [WHO-DD];CHEMBL429876;2-((2S,5R,8S,11S)-5-benzyl-11-(3-guanidinopropyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid;DTXSID9044035;cyclo(arginyl-glycyl-formylaspartyl-N-methylvalyl);cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-N-methyl-L-valyl);CILENGITIDE (MART.);CYCLO(L-ARGINYLGLYCYL-L-.ALPHA.-ASPARTYL-D-PHENYLALANYL-N-METHYL-L-VALYL);2-[(2S,5R,8S,11S)-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-5-(phenylmethyl)-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;2-[(2S,5R,8S,11S)-5-benzyl-11-(3-carbamimidamidopropyl)-7-methyl-3,6,9,12,15-pentaoxo-8-(propan-2-yl)-1,4,7,10,13-pentaazacyclopentadecan-2-yl]acetic acid;C27H40N8O7;cyclo(RGDf-N(Me)V);UNII-4EDF46E4GI;cilengitidum;cyclo-(Arg-Gly-Asp-DPhe-NMeVal);Cilengitide?;NSC-707544;Cyclo(L-arginylglycyl-L-aspartyl-D-phenylalanyl-N-methyl-L-valyl);[(2S,5R,8S,11S)-5-BENZYL-11-(3-CARBAMIMIDAMIDOPROPYL)-8-ISOPROPYL-7-METHYL-3,6,9,12,15-PENTAOXO-1,4,7,10,13-PENTAAZACYCLOPENTADECAN-2-YL]ACETIC ACID;2-((2S,5R,8S,11S)-11-(3-(diaminomethylideneamino)propyl)-7-methyl-3,6,9,12,15-pentaoxo-5-(phenylmethyl)-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl)acetic acid;2-((2S,5R,8S,11S)-5-benzyl-11-(3-carbamimidamidopropyl)-7-methyl-3,6,9,12,15-pentaoxo-8-(propan-2-yl)-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid;Cilengitide trifluoroacetic acid salt;c(RGDfMeV);Cilengitide (USAN/INN);SCHEMBL34082;GTPL6597;DTXCID7024035;CHEBI:177833;EX-A1775;NHA96851;BDBM50235980;NSC774651;s6387;AKOS024257893;AKOS030525213;CS-1211;cyclo(Arg-Gly-Asp-D-Phe-[N-Me]Val);DB11890;NSC-774651;NCGC00386242-02;NCGC00386242-04;AC-35857;AS-72195;DA-51902;HY-16141;NS00069654;SW220134-1;A11657;D03497;Q1091921;BRD-K57252450-001-02-5;[(2S,5R,8S,11S)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13pentaaza-cyclopentadec-2-yl]-acetic acid;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C27H40N8O7 |
M.W/Mr. | 588.7 |
Sequence | Three Letter Code:cyclo[Arg-Gly-Asp-D-Phe-N(Me)Val] |
Biological Activity | Potent and selective inhibitor of integrins αvβ3 and αvβ5 (IC50 values are 4.1 and 70 nM, respectively). Exhibits ~10-fold selectivity over gpIIb/IIIa. Increases endothelial monolayer permeability. Also exhibits antiangiogenic activity. |
Long-term Storage Conditions | Soluble to 10 mg/ml in water |
Shipping Condition | Room temperature in continental US; may vary elsewhere. |
InChI | InChI=1S/C27H40N8O7/c1-15(2)22-25(41)33-17(10-7-11-30-27(28)29)23(39)31-14-20(36)32-18(13-21(37)38)24(40)34-19(26(42)35(22)3)12-16-8-5-4-6-9-16/h4-6,8-9,15,17-19,22H,7,10-14H2,1-3H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30)/t17-,18-,19+,22-/m0/s1 |
InChI Key | AMLYAMJWYAIXIA-VWNVYAMZSA-N |
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. Cationic cell-penetrating peptides are potent furin inhibitors
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.